Toxicology and Pharmacological Interactions of Classic Psychedelics.
Current topics in behavioral neurosciences July 24, 2024 DOI: 10.1007/7854_2024_508 via PubMed
Summary
AI-generated from the abstractAs psychedelics are studied for more medical uses, understanding their adverse effects and interactions with other drugs is increasingly important. This chapter reviews the known toxicology and drug-drug interactions of classic psychedelics, including LSD, psilocybin, DMT, 5-MeO-DMT, mescaline, 2C-B, Bromo-DragonFLY, and 25X-NBOMe.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Drug safety toxicology Adverse effects Drug–drug interactions Psychedelics hallucinogens Biotransformation |
| Citations | 3 |
| Key finding | The chapter summarizes the known toxicology and drug-drug interactions for several classic psychedelics. |
Abstract
As psychedelics are being investigated for more medical indications, it has become important to characterize the adverse effects and pharmacological interactions with these medications. This chapter will summarize what is known about the toxicology and drug-drug interactions for classic psychedelics, such as LSD, psilocybin, DMT, 5-MeO-DMT, mescaline, 2C-B, Bromo-DragonFLY, and 25X-NBOMe.